01 Mar, 2018
Pantherna Therapeutics attended the BIO.NRW Business Angel ZIRKEL in Duesseldorf
Posted at 10:45h
in Allgemein
Dr. Gerrit Maaß, Chief Financial Officer, and Dr. Klaus Giese, Chief Executive Officer, were invited to outline the Company’s future strategy to develop mRNA-based therapeutics (PanRNA Therapeutics) for vascular diseases.